Table 2.
Dual Energy X-ray Absorptiometry (DEXA) of the entire femur.
| BMC (mg) | aBMD (mg/cm2 of HA) | |
|---|---|---|
| Base | 15.3 ± 1.1 | 48.7 ± 2.1 |
| Ctrl | 16.5 ± 1.2 a | 50.2 ± 2.3 |
| BTX | 11.2 ± 0.5 a,b | 39.4 ± 1.0 a,b |
| BTX+Zol | 16.0 ± 1.1 c | 49.5 ± 1.8 c |
16-week-old C57BL/6J female mice immobilized with botulinum toxin (BTX) and treated with zoledronic acid (Zol) compared with baseline (Base) and control (Ctrl) mice. Bone mineral content (BMC), areal bone mineral density (aBMD), and hydroxyapatite (HA).
a
denotes a significant difference (p<0.05) from Base,
b
denotes a significant difference (p<0.05) from Ctrl, and
c
denotes a significant difference (p<0.05) from BTX. Mean ± SD.